The Intersection of Science, Business, and Law
I build bridges between the lab and the market. With a formal background spanning a Ph.D. in Chemical & Biomolecular Engineering, an MBA in Technology Management, and an active pursuit of legal expertise in Intellectual Property and Corporate Law, I architect scalable deep-tech ventures.
As a technology transfer executive and founder, my core focus is identifying transformative innovations—particularly in biotechnology, medical devices, and AI—and accelerating their deployment through strategic industry partnerships and precision capital formation.
Core Expertise
Driving systemic technological advancement via multi-disciplinary strategy.
Technology Commercialization
Moving research out of the laboratory and into the global market through precision licensing, spin-outs, and aggressive go-to-market execution.
Artificial Intelligence
Leveraging frontier machine learning models to accelerate drug discovery, optimize tech transfer, and scale intelligent systems into real-world biotech.
Intellectual Property Strategy
Navigating complex patent landscapes and trade secrets to build highly defensible commercial moats for rapid-growth engineering ventures.
Startup Formation
Acting as a key architect and early-stage executive for deep-tech start-ups, managing everything from capital formation to elite team building.
Industry Partnerships
Structuring mutually beneficial relationships between academic research institutions, tier-one venture capital firms, and Fortune 500 corporations.
Innovation Ecosystems
Cultivating robust environments where concentrated capital, specialized lab infrastructure, and market demand converge to produce category-defining enterprises.
Career Milestones
A trajectory defined by bridging the "Valley of Death" in technology development.
Director of Industry Engagement
Leading industry-sponsored research and technology marketing initiatives. Stewarding an IP pipeline across oncology, energy, and AI-enabled health technologies, and accelerating deal flow through the Preferred IP Program.
Senior Associate & Fellowship Director
Managed a significant portfolio of medical device and digital health inventions. Designed risk-adjusted NPV models and go/no-go milestones, and co-directed the commercialization fellowship to train early-career scientists.
Assoc. Director, Technology Marketing
Devised market-entry and funding strategies for 100+ life-science disclosures, driving a 40% increase in licensing revenue year-over-year. Mentored faculty founders, catalyzing the launch of eight VC and grant-backed startups.
Co-Founder, CEO & Principal Investigator
Architected and scaled multiple deep-tech ventures. Served as CEO of DxRuptive, BD Executive for Zenus, Co-Founder of Luminostics, and Principal Investigator securing >$5M in DoD/DARPA/NIH funding for advanced diagnostics at Lynntech.
Catalyzing the Next Decade
Thought leadership and active focus areas driving future development.
AI-Enabled Innovation
The AI-First Approach to Discovery
Exploring how generative models and specialized machine learning architectures are fundamentally rewriting the strict timelines for drug discovery, material development, and patent drafting workflows. Integrating Large Language Models directly into the commercialization pipeline to audit massive IP portfolios in seconds.
University Venture
Reimagining Tech Transfer
Developing modern strategies for academic institutions to transition from legacy licensing engines into robust venture creation hubs.
Deep-Tech Policy
Building Defensive Moats
Evaluating incoming geopolitical shifts in patent strategy to ensure nascent tech startups can deploy capital efficiently without litigation risks.
Ready to architect the future?
Always open to high-leverage conversations regarding venture creation, deep-tech strategy, and opportunities at the intersection of AI and intellectual property.